FSD Pharma Strengthens Drug Development with GW Executive
FSD Pharma (CSE:HUGE,OTCQB:FSDDF,FRA:0K9) may have a big focus on cannabis but, as of late, the company is gearing up to bring its products to the pharmaceutical market.
FSD Pharma (CSE:HUGE,OTCQB:FSDDF,FRA:0K9) may have a big focus on cannabis but, as of late, the company is gearing up to bring its products to the pharmaceutical market.
Khiron Life Sciences Corp. (TSXV:KHRN), an integrated medical cannabis company with its core operations in Colombia, announced today that the Company has closed the previously announced MOU with Dayacann, holder of Chile’s first medical cannabis cultivation license.
TORONTO, Jan. 23, 2019 /CNW/ – Enforcer Gold Corp (“Enforcer” or the “Company”) (TSX-V: VEIN; FSE: N071) announces the departure of Steve Roebuck as President, CEO and Director of Enforcer effective immediately. The Company announces that Steve Dunn, Director, has been appointed CEO on an interim basis and Edward Milewski as Director.
NEW YORK, January 22, 2019 /PRNewswire/ — Cannabidiol, or CBD, has become increasingly popular due to its therapeutic and relaxing effects. CBD is the non-psychoactive component of cannabis and is widely being used to treat medical conditions such as epilepsy and arthritis without feeling the effects associated with THC. It also doesn’t matter if CBD is being used for medical or recreational purposes, as there is a large demand overall. According to data compiled by Brightfield Group, the U.S. CBD market is expected to reach USD 22 Billion by 2022, outpacing the rest of the cannabis market combined. The market is expected to grow due to the versatile uses of the derivative, as CBD is commonly used for medical applications, health and wellness, beauty
Continue Reading “Positive Health Effects Key as CBD Continues to Garner Attention”
TORONTO, Jan. 17, 2019 /CNW/ – Khiron Life Sciences Corp. (“Khiron” or the “Company”) (TSXV: KHRN), (OTCQB: KHRNF), (Frankfurt: A2JMZC), an integrated medical cannabis company with its core operations in Colombia, announced today that the Company will co-host Cannamexico World Summit 2019, a comprehensive cannabis symposium taking place April 25 – 26 at Centro Fox, Guanajuato, Mexico. This is the second annual Cannamexico event and is recognized as the first of its kind cannabis summit in Mexico.
an 17, 2019 (TheNewswire.ca via COMTEX) — (via TheNewswire) Quebec, QC / TheNewswire / January 17th, 2019 – NuRAN Wireless Inc. (“NuRAN Wireless” or the “Company”) (cse:NUR) NRRWF, -7.96% (1RN) is pleased to announce the conclusion of a conditional trilateral sales agreement with an undisclosed African Mobile Network Operator (the “MNO” or the “Client”) and Spacecom, operator of the AMOS satellite fleet. NuRAN will be offering a turnkey solution to the undisclosed MNO under the Mobile Network Enabler (“MNE”) business model which was launched on October 9, 2018.
TORONTO, ON / ACCESSWIRE / January 16, 2019 / Gratomic Inc. (“Gratomic” or the “Company”) (TSX-V: GRAT) (CB81-FRANKFURT) a vertically integrated graphite to graphenes, advanced materials company is pleased to announce the development of Gratomic’s new Graphene Ultra Fuel Efficient Tires (GUET) with certification and terrain testing targeted for completion in Q3, 2019.
Quebec, QC, January 15th, 2019 – NuRAN Wireless Inc. (“NuRAN Wireless” or the “Company”) (CSE: NUR) (OTC: NRRWF) (FSE: 1RN) is pleased to announce the appointment of telecom industry veteran Christian de Faria as a non-executive director. Based in Kenya, Mr. de Faria has held key executive positions at multiple leading mobile network operators over the past 25 years, including:
Mississauga, Ontario – January 14, 2019 (Newsfile Corp.) (Investorideas.com Newswire) Bee Vectoring Technologies International Inc. (TSXV: BEE) (OTCQB: BEVVF) (“BVT”) announced today that it has submitted results from the US Environmental Protection Agency’s (EPA) requested honey bee larval safety study along with a weight of evidence document in support of its regulatory approval process with the EPA.
MONTRÉAL, Jan. 11, 2019 /CNW/ – Cannara Biotech Inc. (“Cannara” or the “Company”), a vertically integrated Cannabis company focused on cannabis derivative products, is pleased to announce that its common shares will begin trading on Monday, January 14, 2019 on the Canadian Securities Exchange (“CSE”) under the symbol “LOVE”.